Risa Murakami, Tomohiro Shiraishi, Mikiko Imamura, Akihiko Takushima, Hirotaka Suga
{"title":"乳房重建后疤痕愈合:亚洲患者的5年随访。","authors":"Risa Murakami, Tomohiro Shiraishi, Mikiko Imamura, Akihiko Takushima, Hirotaka Suga","doi":"10.53045/jprs.2024-0013","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Hypervascularity, hypertrophy, and hyperpigmentation of breast scars often persist for several years after reconstruction. There are few reports on the long-term follow-up of postoperative scars after breast reconstruction. We previously reported that at 1 year after reconstruction, >30% of Asian patients showed abnormal scars. In this study, we followed these patients for as long as 5 years postoperatively.</p><p><strong>Methods: </strong>We followed 101 Asian patients who underwent immediate two-stage implant-based breast reconstructions between 2013 and 2017 and still had abnormal scars involving hypervascularity, hypertrophy, or hyperpigmentation at 1 year postoperatively. We conducted annual follow-up for an additional 4 years, assessing the time until improvement and performing statistical analysis of factors related to the persistence and healing of abnormal scars.</p><p><strong>Results: </strong>Hypervascularity improved in 12%, 37%, 68%, and 82% of patients at 2, 3, 4, and 5 years, respectively. Most cases improved between 3 and 4 years postoperatively. Among the patients with both hypervascularity and hypertrophy at 1 year, 36% had residual hypervascularity at 5 years compared with 9.8% of those with hypervascularity only at 1 year. Hypertrophy improved within 5 years in 56% of the cases. Hyperpigmentation improved within 5 years in only 21% of the cases. There was no significant association between abnormal scars and age or body mass index.</p><p><strong>Conclusions: </strong>Even in Asian patients with persistent hypervascularity of breast scars, most cases improve within 5 years after reconstruction. However, hypervascularity tends to persist in cases that also show hypertrophy. Compared with hypervascularity and hypertrophy, hyperpigmentation showed worse 5-year improvement.</p>","PeriodicalId":520467,"journal":{"name":"Journal of plastic and reconstructive surgery","volume":"4 1","pages":"20-25"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11950569/pdf/","citationCount":"0","resultStr":"{\"title\":\"Scar Healing after Breast Reconstruction: A 5-year Follow-up in Asian Patients.\",\"authors\":\"Risa Murakami, Tomohiro Shiraishi, Mikiko Imamura, Akihiko Takushima, Hirotaka Suga\",\"doi\":\"10.53045/jprs.2024-0013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Hypervascularity, hypertrophy, and hyperpigmentation of breast scars often persist for several years after reconstruction. There are few reports on the long-term follow-up of postoperative scars after breast reconstruction. We previously reported that at 1 year after reconstruction, >30% of Asian patients showed abnormal scars. In this study, we followed these patients for as long as 5 years postoperatively.</p><p><strong>Methods: </strong>We followed 101 Asian patients who underwent immediate two-stage implant-based breast reconstructions between 2013 and 2017 and still had abnormal scars involving hypervascularity, hypertrophy, or hyperpigmentation at 1 year postoperatively. We conducted annual follow-up for an additional 4 years, assessing the time until improvement and performing statistical analysis of factors related to the persistence and healing of abnormal scars.</p><p><strong>Results: </strong>Hypervascularity improved in 12%, 37%, 68%, and 82% of patients at 2, 3, 4, and 5 years, respectively. Most cases improved between 3 and 4 years postoperatively. Among the patients with both hypervascularity and hypertrophy at 1 year, 36% had residual hypervascularity at 5 years compared with 9.8% of those with hypervascularity only at 1 year. Hypertrophy improved within 5 years in 56% of the cases. Hyperpigmentation improved within 5 years in only 21% of the cases. There was no significant association between abnormal scars and age or body mass index.</p><p><strong>Conclusions: </strong>Even in Asian patients with persistent hypervascularity of breast scars, most cases improve within 5 years after reconstruction. However, hypervascularity tends to persist in cases that also show hypertrophy. Compared with hypervascularity and hypertrophy, hyperpigmentation showed worse 5-year improvement.</p>\",\"PeriodicalId\":520467,\"journal\":{\"name\":\"Journal of plastic and reconstructive surgery\",\"volume\":\"4 1\",\"pages\":\"20-25\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11950569/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of plastic and reconstructive surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53045/jprs.2024-0013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/27 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of plastic and reconstructive surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53045/jprs.2024-0013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/27 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Scar Healing after Breast Reconstruction: A 5-year Follow-up in Asian Patients.
Objectives: Hypervascularity, hypertrophy, and hyperpigmentation of breast scars often persist for several years after reconstruction. There are few reports on the long-term follow-up of postoperative scars after breast reconstruction. We previously reported that at 1 year after reconstruction, >30% of Asian patients showed abnormal scars. In this study, we followed these patients for as long as 5 years postoperatively.
Methods: We followed 101 Asian patients who underwent immediate two-stage implant-based breast reconstructions between 2013 and 2017 and still had abnormal scars involving hypervascularity, hypertrophy, or hyperpigmentation at 1 year postoperatively. We conducted annual follow-up for an additional 4 years, assessing the time until improvement and performing statistical analysis of factors related to the persistence and healing of abnormal scars.
Results: Hypervascularity improved in 12%, 37%, 68%, and 82% of patients at 2, 3, 4, and 5 years, respectively. Most cases improved between 3 and 4 years postoperatively. Among the patients with both hypervascularity and hypertrophy at 1 year, 36% had residual hypervascularity at 5 years compared with 9.8% of those with hypervascularity only at 1 year. Hypertrophy improved within 5 years in 56% of the cases. Hyperpigmentation improved within 5 years in only 21% of the cases. There was no significant association between abnormal scars and age or body mass index.
Conclusions: Even in Asian patients with persistent hypervascularity of breast scars, most cases improve within 5 years after reconstruction. However, hypervascularity tends to persist in cases that also show hypertrophy. Compared with hypervascularity and hypertrophy, hyperpigmentation showed worse 5-year improvement.